Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

NCT05399498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Borderline Personality Disorder
Major Depressive Disorder

Interventions

DRUG: Psilocybin

Sponsor

University of Chicago

Collaborators

Usona Institute